JPS5919095B2 - Quinoline derivatives and their production method - Google Patents

Quinoline derivatives and their production method

Info

Publication number
JPS5919095B2
JPS5919095B2 JP52074648A JP7464877A JPS5919095B2 JP S5919095 B2 JPS5919095 B2 JP S5919095B2 JP 52074648 A JP52074648 A JP 52074648A JP 7464877 A JP7464877 A JP 7464877A JP S5919095 B2 JPS5919095 B2 JP S5919095B2
Authority
JP
Japan
Prior art keywords
compound
general formula
reaction
hours
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52074648A
Other languages
Japanese (ja)
Other versions
JPS549284A (en
Inventor
義「あき」 真鍋
和央 坂野
量之 中川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP52074648A priority Critical patent/JPS5919095B2/en
Publication of JPS549284A publication Critical patent/JPS549284A/en
Publication of JPS5919095B2 publication Critical patent/JPS5919095B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】 本発明は新規なキノリン誘導体に関す。[Detailed description of the invention] The present invention relates to novel quinoline derivatives.

本発明の化合物は、一般式(式中Xはハロゲン原子を示
す。
The compound of the present invention has the general formula (wherein X represents a halogen atom).

またR_1、R_2及びR_3は水素原子または低級ア
ルコキシ基を示す。但しR_1及びR_3が低級アルコ
キシ基のときはR_2は水素原子を、R_、及びR_3
が水素原子のときはR_2は低級アルコキシ基を、また
R_1及びR_2が水素原子のときはR_3は低級アル
コキシ基を示す)で表わされる。該化合物はそれ自体抗
菌活性作用を有し抗菌剤として有用であり、また医薬品
合成の中間体としても有用である。一般式〔I〕中R_
1−R_3で示される低級アルコキシ基としては炭素数
1〜4の直鎖もしくは分枝状のアルコキシ基を挙げるこ
とができ、具体的にはメトキシ、エトキシ、プロポキシ
、イソプロポキシ、ブトキシ、tert−ブトキシ基等
を例示できる。
Moreover, R_1, R_2 and R_3 represent a hydrogen atom or a lower alkoxy group. However, when R_1 and R_3 are lower alkoxy groups, R_2 is a hydrogen atom, R_ and R_3
When is a hydrogen atom, R_2 is a lower alkoxy group, and when R_1 and R_2 are hydrogen atoms, R_3 is a lower alkoxy group). The compound itself has antibacterial activity and is useful as an antibacterial agent, and is also useful as an intermediate for pharmaceutical synthesis. R_ in general formula [I]
The lower alkoxy group represented by 1-R_3 can include straight chain or branched alkoxy groups having 1 to 4 carbon atoms, specifically methoxy, ethoxy, propoxy, isopropoxy, butoxy, and tert-butoxy. Examples include groups.

またXで示されるハロゲン原子としては塩素原子、臭素
原子、沃素原子等を例示出来る。本発明の化合物のうち
代表的なものを以下に掲げる。O2・4−ジクロルー5
−プロポキシキノリン○2・4−ジクロルー6−メトキ
シキノリン。
Examples of the halogen atom represented by X include chlorine atom, bromine atom, and iodine atom. Representative compounds of the present invention are listed below. O2.4-dichlororu5
-Propoxyquinoline ○ 2,4-dichloro-6-methoxyquinoline.

2・4−ジクロルー8−メトキシキノリン本発明の化合
物は種々の方法により合成されるが、そのうち好ましい
一例を挙げれば下記反応行程式−1に示す通り公知の一
般式〔〕で表わされるベンゼン誘導体から製造すること
ができる。
2,4-dichloro-8-methoxyquinoline The compound of the present invention can be synthesized by various methods, but one preferred example is from a benzene derivative represented by the known general formula [] as shown in the following reaction scheme-1. can be manufactured.

反応行程式−1即ち公知の一般式〔〕の化合物を公知の
縮合剤の存在下に閉環反応させることにより一般式〔1
−1〕で表わされる化合物が製造され、一般式〔1−1
〕の化合物を加水分解することにより一般式〔−2〕で
表わされる化合物が製造される。
Reaction Scheme-1 That is, a compound of the known general formula [] is subjected to a ring-closing reaction in the presence of a known condensing agent to obtain the compound of the general formula [1].
-1] is produced, and a compound represented by the general formula [1-1] is produced.
] A compound represented by the general formula [-2] is produced by hydrolyzing the compound.

一般式〔−3〕で表わされる化合物は公知の縮合剤の存
在下に公知の一般式〔〕の化合物を閉環反応させること
により製造される。一般式〔1−1〕の化合物は一般式
〔1−3〕の化合物をハロゲン化することによつても製
造される。一般式〔1−1]の化合物は一般式〔]の化
合物に無溶媒でもしくは通常の不活性溶媒中オキシ塩化
リン、オキシ臭化リン、五塩化リン、五臭化リン、三塩
化リン等のハロゲン化合物等の縮合剤を通常30〜15
0℃、好ましくは50〜100℃で1〜24時間程度反
応させることにより製造される。斯かる不活性溶媒とし
ては例えばクロロホルム、ジクロロメタン、1・2−ジ
クロロエタン等のハロゲン化炭化水素類、エーテル、ジ
オキサン等のエーテル類、ベンゼン、トルエン、キシレ
ン等の芳香族炭化水素類等を挙げることができる。一般
式〔〕の化合物と縮合剤との使用割合は特に限定されず
広い範囲から適宜選択されるが、通常前者に対して後者
を2〜20倍モル、好ましくは7〜12倍モル使用する
のがよい。一般式〔1−1〕の化合物の加水分解反応は
通常使用されている加水分解触媒、例えば塩酸、臭化水
素酸等のハロゲン化水素酸、硫酸、燐酸等の無機酸、水
酸化カリウム、水酸化ナトリウム等のアルカリ金属水酸
化物、炭酸ナトリウム、炭酸力リウム、炭酸水素ナトリ
ウム等の無機アルカリ化合物等の存在下に、通常50〜
150℃、好ましくは70〜100℃に加熱して3〜2
4時間程度反応させればよい。一般式〔1−2]の化合
物は一般式〔1−1〕の化合物をアルカリ金属アルコキ
シドで処理し、次いでこれを加水分解することによつて
も製造される。
The compound represented by the general formula [-3] is produced by subjecting a compound of the known general formula [] to a ring-closing reaction in the presence of a known condensing agent. The compound of general formula [1-1] can also be produced by halogenating the compound of general formula [1-3]. The compound of general formula [1-1] is prepared by adding phosphorus oxychloride, phosphorus oxybromide, phosphorus pentachloride, phosphorus pentabromide, phosphorus trichloride, etc. to the compound of general formula [] without a solvent or in a common inert solvent. The condensing agent such as a halogen compound is usually 30 to 15
It is produced by reacting at 0°C, preferably 50 to 100°C, for about 1 to 24 hours. Examples of such inert solvents include halogenated hydrocarbons such as chloroform, dichloromethane, and 1,2-dichloroethane, ethers such as ether and dioxane, and aromatic hydrocarbons such as benzene, toluene, and xylene. can. The ratio of the compound of general formula [] and the condensing agent to be used is not particularly limited and can be selected appropriately from a wide range, but usually the latter is used in a molar range of 2 to 20 times, preferably 7 to 12 times the former. Good. The hydrolysis reaction of the compound of general formula [1-1] can be carried out using commonly used hydrolysis catalysts, such as hydrohalic acids such as hydrochloric acid and hydrobromic acid, inorganic acids such as sulfuric acid and phosphoric acid, potassium hydroxide, water, etc. Usually in the presence of an alkali metal hydroxide such as sodium oxide, an inorganic alkali compound such as sodium carbonate, hydrium carbonate, sodium bicarbonate, etc.
Heating to 150℃, preferably 70 to 100℃ for 3 to 2
It is enough to react for about 4 hours. The compound of general formula [1-2] can also be produced by treating the compound of general formula [1-1] with an alkali metal alkoxide and then hydrolyzing the same.

一般式〔1−1〕の化合物とアルカリ金属アルコキシド
との反応は通常の不活性溶媒、例えばメタノール、エタ
ノール、ブタノール、Tert−ブタノール等の低級ア
ルコール類、エーテル、ジオキサン等のエーテル類、ベ
ンゼン、トルエン、キシレン等の芳香族炭化水素類、ジ
メチルスルホキシド、ジメチルホルムアミド等の溶媒中
、通常室温〜溶媒の沸点の範囲内、好ましくは60〜8
0℃で5分〜10時間程度行なえばよい。使用されるア
ルカリ金属アルコキシドとしては公知のものを広く用い
ることができ、具体的にはナトリウムメトキシド、カリ
ウムエトキシド、カリウムブトキシド、ナトリウムTe
rt−ブトキシド、カリウムTert−ブトキシド等を
例示できる。これらのうちナトリウムTert−ブトキ
シド及びカリウムTert−ブトキシドが最も好ましい
。一般式〔11〕の化合物とアルカリ金属アルコキシド
との使用割合は特に限定されず広い範囲内で適宜選択さ
れるが、前者に対して後者を通常等モル〜2倍モル、好
ましくは等モル〜1.5倍モル量使用するのがよい。一
般式〔1−3〕の化合物は無溶媒でもしくは通常の不活
性溶媒中にて縮合剤を用いて一般式〔〕の化合物を閉環
させることにより製造される。
The reaction between the compound of general formula [1-1] and an alkali metal alkoxide can be carried out using a conventional inert solvent, such as lower alcohols such as methanol, ethanol, butanol, and tert-butanol, ethers such as ether, dioxane, benzene, and toluene. , aromatic hydrocarbons such as xylene, dimethyl sulfoxide, dimethyl formamide, etc., usually within the range of room temperature to the boiling point of the solvent, preferably 60 to 8
It may be carried out at 0°C for about 5 minutes to 10 hours. A wide variety of known alkali metal alkoxides can be used, and specific examples include sodium methoxide, potassium ethoxide, potassium butoxide, and sodium Te.
Examples include rt-butoxide and potassium tert-butoxide. Of these, sodium tert-butoxide and potassium tert-butoxide are most preferred. The ratio of the compound of general formula [11] and the alkali metal alkoxide is not particularly limited and is appropriately selected within a wide range, but the latter is usually equal to 2 times the amount of the former, preferably equal to 1 times the amount of the latter. It is preferable to use .5 times the molar amount. The compound of general formula [1-3] is produced by ring-closing the compound of general formula [] using a condensing agent without a solvent or in a common inert solvent.

この際使用される縮合剤としては五酸化リン、弗化水素
、硫酸、ポリリン酸、塩化アルミニウム、塩化亜鉛等の
ルイス酸等を例示でき、また不活性溶媒としてはクロロ
ホルム、ジクロロメタン、1・2−ジクロロエタン等の
ハロゲン化炭化水素類、エーテル、ジオキサン等のエー
テル類、ニトロベンゼン、クロロベンゼン等の芳香族炭
化水素類等を例示できる。縮合剤としてはポリリン酸が
最も好ましい。一般式〔〕の化合物と縮合剤との使用割
合は特に限定がなく広い範囲から適宜選択されるが、前
者に対して後者を通常等モル〜10倍モル、好ましくは
3〜6倍モル量とするのがよい。特にポリリン酸を用い
る場合には無溶媒下で一般式〔〕の化合物に対して通常
等量〜10倍量(重量)、好ましくは3〜5倍量(重量
)用いるのがよい。この閉環反応は通常50〜250℃
、好ましくは70〜200℃で行なうのがよく、反応時
間は通常20分〜6時間程度である。一般式〔1−1〕
の化合物は、無溶媒もしくは通常の不活性溶媒中ハロゲ
ン化剤の存在下一般式〔1−3〕の化合物をハロゲン化
することによつても製造される。
Examples of condensing agents used in this case include Lewis acids such as phosphorus pentoxide, hydrogen fluoride, sulfuric acid, polyphosphoric acid, aluminum chloride, and zinc chloride, and examples of inert solvents include chloroform, dichloromethane, 1,2- Examples include halogenated hydrocarbons such as dichloroethane, ethers such as ether and dioxane, and aromatic hydrocarbons such as nitrobenzene and chlorobenzene. Polyphosphoric acid is most preferred as the condensing agent. The ratio of the compound of the general formula [] and the condensing agent to be used is not particularly limited and may be appropriately selected from a wide range, but the latter is usually used in an equimolar to 10 times molar amount, preferably 3 to 6 times the molar amount of the former. It is better to do so. In particular, when polyphosphoric acid is used, it is usually used in an equivalent amount to 10 times the amount (by weight), preferably 3 to 5 times the amount (by weight) of the compound of the general formula [] in the absence of a solvent. This ring-closing reaction is usually carried out at 50-250°C.
The reaction is preferably carried out at a temperature of 70 to 200°C, and the reaction time is usually about 20 minutes to 6 hours. General formula [1-1]
The compound can also be produced by halogenating the compound of general formula [1-3] in the presence of a halogenating agent without a solvent or in a conventional inert solvent.

斯かる反応に使用されるハロゲン化剤としては公知のも
のを広く使用でき、例えばオキシ塩化リン、オキシ臭化
リン、五塩化リン、五臭化リン、三塩化リン、塩化チオ
ニル等を挙げることができる。一般式〔1−3〕の化合
物とハロゲン化剤との使用割合は特に限定されず広い範
囲から適宜選択されるが、溶媒中で反応を行なう場合に
は前者に対して後者を通常2〜10倍モル、好ましくは
3〜6倍モル使用するのがよく、また無溶媒下で反応を
行なう場合には前者に対して後者を通常大過剰量使用す
るのがよい。この反応に使用される不活性溶媒としては
例えばクロロホルム、ジクロロメタン、1・2−ジクロ
ロエタン等のハロゲン化炭化水素類、エーテル、ジオキ
サン等のエーテル類、ベンゼン、トルエン、キシレン等
の芳香族炭化水素類等を挙げることができる。このハロ
ゲン化反応は通常室温〜100℃、好ましくは30〜8
0℃で行なうのがよく、反応時間は通常1〜12時間程
度でよい。斯くして製造される本発明化合物は従来公知
の慣用手段、例えば沢過、抽出、再結晶等により容易に
単離、精製される。
As the halogenating agent used in such a reaction, a wide variety of known agents can be used, such as phosphorus oxychloride, phosphorus oxybromide, phosphorus pentachloride, phosphorus pentabromide, phosphorus trichloride, thionyl chloride, etc. can. The ratio of the compound of general formula [1-3] and the halogenating agent is not particularly limited and is appropriately selected from a wide range, but when the reaction is carried out in a solvent, the latter is usually 2 to 10% of the former. It is preferable to use twice the mole, preferably 3 to 6 times the mole, and when the reaction is carried out without a solvent, the latter is usually used in a large excess amount relative to the former. Examples of inert solvents used in this reaction include halogenated hydrocarbons such as chloroform, dichloromethane, and 1,2-dichloroethane, ethers such as ether and dioxane, and aromatic hydrocarbons such as benzene, toluene, and xylene. can be mentioned. This halogenation reaction is usually carried out at room temperature to 100°C, preferably at 30 to 8°C.
The reaction is preferably carried out at 0°C, and the reaction time is usually about 1 to 12 hours. The compound of the present invention thus produced can be easily isolated and purified by conventionally known methods such as filtering, extraction, recrystallization, etc.

斯くして得られる本発明化合物、例えば5・8−ジアル
コキシ−4−ハロゲノカルボスチリル誘導体は下記反応
行程式−2に示すようにβ−プロツカ一剤合成の中間体
である5・8−ジヒドロキシ−3・4−ジヒドロカルボ
スチリルに誘導することができる。
The compound of the present invention thus obtained, for example, a 5,8-dialkoxy-4-halogenocarbostyryl derivative, is a 5,8-dihydroxy intermediate for the synthesis of β-Protka as shown in the following reaction scheme-2. -3,4-dihydrocarbostyryl.

反応行程式−2 (上式においてRは低級アルキル基を示し、Xは前記に
同じ)従来5・8−ジヒドロキシ−3・4−ジヒドロカ
ルボスチリルを製造する方法としては特公昭46−38
788号、特開昭51−6971号、特開昭51−69
72号、特開昭51−6973号及び特開昭51−69
74号に記載の方法を適宜組み合わせて下記反応行程式
−3に示す方法が知られているに過ぎない。
Reaction Scheme-2 (In the above formula, R represents a lower alkyl group, and X is the same as above) Conventionally, as a method for producing 5,8-dihydroxy-3,4-dihydrocarbostyryl, Japanese Patent Publication No. 46-38
No. 788, JP-A-51-6971, JP-A-51-69
No. 72, JP-A-51-6973 and JP-A-51-69
The only known method is a combination of the methods described in No. 74 as shown in Reaction Scheme-3 below.

反応行程式−3 しかしながら上記従来法では出発原料が高価でしかも複
雑な反応であり全収率が8〜12%と極めて低く工業化
には非常に難点があつた。
Reaction Scheme-3 However, in the above conventional method, the starting materials are expensive, the reaction is complicated, and the overall yield is extremely low at 8 to 12%, making it extremely difficult to commercialize.

これに比して本発明の製造原料である一般式〔〕の化合
物は下記反応行程式〔]に示す如く安価で入手容易な一
般式〔〕のベンゼン誘導体から容易に得られる化合物で
ある。(上式においてR1は前記に同じ) 一般式〔〕の化合物を出発原料とし、一般式〔〕の化合
物、本発明化合物を経て5・8−ジヒドロキシ−3・4
−ジヒドロカルボスチリルを得る方法では全収率が32
%と従来法に比してはるかに高収率であり、しかも出発
原料についてもずつと安価であり、製造コストでは従来
法の1/20であつて極めて好ましい製造法である。
In contrast, the compound of the general formula [], which is the raw material for the production of the present invention, is a compound that can be easily obtained from the benzene derivative of the general formula [], which is inexpensive and easily available, as shown in the reaction scheme [] below. (In the above formula, R1 is the same as above) Using the compound of general formula [] as a starting material, passing through the compound of general formula [] and the compound of the present invention, 5,8-dihydroxy-3,4
-The method for obtaining dihydrocarbostyril has an overall yield of 32
%, the yield is much higher than that of the conventional method, the starting materials are also much cheaper, and the production cost is 1/20 of the conventional method, making it an extremely preferable production method.

本発明の一般式〔1−3〕の化合物の4位の水酸基の除
去は通常のフエノール性水酸基を除去する反応が適用で
きるが、例えば一般式〔1−3〕の化合物を直接還元す
るか或は4位の水酸基を基R3O−(R3はアルキルス
ルホニル基、アリールスルホニル基又は〔]〔、})等
の通常のフエノール性水酸基を脱離するための基に変換
したのちこれを還元することによつても除去できる。
To remove the hydroxyl group at position 4 of the compound of general formula [1-3] of the present invention, a usual reaction for removing a phenolic hydroxyl group can be applied, but for example, the compound of general formula [1-3] may be directly reduced or converts the 4-position hydroxyl group to a group R3O- (R3 is an alkylsulfonyl group, an arylsulfonyl group, or [][, }), which is a group for eliminating a normal phenolic hydroxyl group, and then reduces this. Even if it gets twisted, it can be removed.

本発明をより一層明らかにするために実施例及び参考例
を以下に掲げる。
Examples and reference examples are listed below in order to further clarify the present invention.

実施例 1 N−カルボキシアセチル−2・5−ジメトキシアニリン
268fをPOCl3l2OOmlに加え2時間還流す
る。
Example 1 268f of N-carboxyacetyl-2,5-dimethoxyaniline was added to 3l2OOml of POCl and refluxed for 2 hours.

POCl3を回収後氷水10.eに徐徐にあける。析出
晶を沢取、水洗、乾燥して2・4−ジクロロ−5・8−
ジメトキシキノリン2537を得る。融点121〜12
6℃これをメタノール2200m1より再結晶する。黄
色針状晶、融点129〜130℃実施例 2 4−ヒドロキシ−5・8−ジメトキシカルボスチリル2
.57をPOCl325mlに加え3時間還流したのち
、減圧下濃縮し、得られた残留物に水を加えて析出晶を
f取し、メタノールから再結晶して黄色針状晶の2・4
−ジクロロ−5・8−ジメトキシキノリン2,17を得
る。
After collecting POCl3, add ice water 10. Open slowly to e. Collect the precipitated crystals, wash with water, and dry to obtain 2,4-dichloro-5,8-
Dimethoxyquinoline 2537 is obtained. Melting point 121-12
This was recrystallized at 6°C from 2200 ml of methanol. Yellow needle crystals, melting point 129-130°C Example 2 4-Hydroxy-5,8-dimethoxycarbostyryl 2
.. 57 was added to 325 ml of POCl and refluxed for 3 hours, then concentrated under reduced pressure. Water was added to the resulting residue to collect precipitated crystals, which were recrystallized from methanol to give 2.4 yellow needle-shaped crystals.
-Dichloro-5,8-dimethoxyquinoline 2,17 is obtained.

融点129〜130℃参考例 1 2・4−ジクロロ−5・8−ジメトキシキノリン57、
濃硫酸5m1及び50%エタノール水溶液500m1を
9時間還流する。
Melting point: 129-130°C Reference example 1 2,4-dichloro-5,8-dimethoxyquinoline 57,
5 ml of concentrated sulfuric acid and 500 ml of 50% ethanol aqueous solution are refluxed for 9 hours.

反応終了後溶媒を減圧留去し乾固した後、水500m1
を加えて析出晶を沢取、乾燥する。これを90%メタノ
ール水溶液より再結晶して黄色無定形晶の4−クロロ−
5・8−ジメトキシカルボスチリル2.37を得る。融
点208〜209℃参考例 2 2・4−ジクロロ−5・8−ジメトキシキノリン26y
をTert−プタノール400m1に溶かし、カリウム
Tert−ブトキシド1.5当量を加え窒素気流下3時
間還流する。
After the reaction was completed, the solvent was distilled off under reduced pressure and dried, and then 500ml of water was added.
Add a lot of precipitated crystals, and dry. This was recrystallized from a 90% aqueous methanol solution to form yellow amorphous crystals of 4-chloro-
2.37 of 5,8-dimethoxycarbostyryl are obtained. Melting point: 208-209°C Reference example 2 2,4-dichloro-5,8-dimethoxyquinoline 26y
was dissolved in 400 ml of tert-butanol, 1.5 equivalents of potassium tert-butoxide were added, and the mixture was refluxed for 3 hours under a nitrogen atmosphere.

反応終了後減圧下にTert−ブタノール約200m1
を留去したのち、水1000m1に注ぎ込み、次いで濃
塩酸100m1を加え約PH−1としたのち70℃で1
時間加熱する。冷却後析出晶を沢取、水洗、乾燥後90
%メタノール水溶液より再結晶して黄色無定形晶の4ー
クロロ−5・8−ジメトキシカルボスチリルを得る。収
量22,57、融点208〜209℃実施例 34−ヒ
ドロキシ−8−メトキシカルボスチリル1.57をPO
Cl32Omlに加え、3時間還流したのち、減圧下濃
縮し、得られた残留物に水を加えて析出晶を沢取し、メ
タノールから再結晶に淡黄色針状晶の2・4−ジクロル
−8−メトキシキノリンを得る。
After the reaction is complete, add about 200ml of tert-butanol under reduced pressure.
After distilling off, it was poured into 1,000 ml of water, and then 100 ml of concentrated hydrochloric acid was added to bring the pH to about 1, and then the pH was heated to 1 at 70°C.
Heat for an hour. After cooling, collect the precipitated crystals, wash with water, and dry for 90 minutes.
% methanol aqueous solution to obtain 4-chloro-5,8-dimethoxycarbostyryl as yellow amorphous crystals. Yield 22.57, melting point 208-209℃Example 34-hydroxy-8-methoxycarbostyryl 1.57 was PO
After adding to 20 ml of Cl and refluxing for 3 hours, it was concentrated under reduced pressure. Water was added to the obtained residue to collect a lot of precipitated crystals, and recrystallized from methanol to give pale yellow needle-like crystals of 2,4-dichloro-8. -Methoxyquinoline is obtained.

収量1.37、融点144℃参考例 3 2・4−ジクロル−8−メトキシキノリン200ヮを濃
硫酸37、水10m1及びエタノール10m1に加え、
5時間還流したのち減圧下濃縮し、得られた残留物に水
を加え析出晶を沢取し、ベンゼンから再結晶して無色針
状晶の4−クロル−8メトキシカルボスチリルを得る。
Yield: 1.37, melting point: 144°C Reference Example 3 Add 200% of 2,4-dichloro-8-methoxyquinoline to 37% of concentrated sulfuric acid, 10ml of water and 10ml of ethanol,
After refluxing for 5 hours, the mixture was concentrated under reduced pressure, water was added to the resulting residue, the precipitated crystals were collected, and recrystallized from benzene to obtain colorless needle-like crystals of 4-chloro-8methoxycarbostyryl.

収量180即、融点186〜187゜C実施例 4 N−カルボキシアセチル−2−メトキシアニリン2.5
yをPOCl3l2mlに加え2時間還流する。
Yield 180, melting point 186-187°C Example 4 N-carboxyacetyl-2-methoxyaniline 2.5
y was added to 3 liters of POCl (2 ml) and refluxed for 2 hours.

減圧下POCl3を除去したのち氷水100m1に注ぎ
析出する結晶を沢取し、メタノールから再結晶して淡黄
色針状晶の2・4−ジクロル−8−メトキシキノリンを
得る。収量1.8y、融点144℃実施例 5N−カル
ボキシアセチル−4−メトキシアニリン137をPOC
l36Omlに加え2時間還流する。
After removing POCl3 under reduced pressure, the mixture was poured into 100 ml of ice water to collect the precipitated crystals, and recrystallized from methanol to obtain 2,4-dichloro-8-methoxyquinoline in the form of pale yellow needles. Yield 1.8y, melting point 144°C Example 5N-carboxyacetyl-4-methoxyaniline 137 was POC
1360ml and refluxed for 2 hours.

POCl3を減圧下濃縮したのち、氷水11に徐々にあ
ける。析出晶を沢取、水洗、乾燥する。得られた粗結晶
をメタノールから再結晶して無色針状晶の2・4−ジク
ロル−6−メトキシキノリンを得る。収量127、融点
175〜176℃参考例 4 4−クロロ−5・8−ジメトキシカルボスチリル157
を60%メタノール500m1又はエタノール300m
1に加え、次いでこれに還元触媒1.5y及び当量のN
aOH水溶液を加え、H2lOk9/Cd、50〜60
℃にて2時間攪拌する。
After concentrating POCl3 under reduced pressure, it was gradually poured into ice water 11. Collect the precipitated crystals, wash with water, and dry. The obtained crude crystals are recrystallized from methanol to obtain colorless needle-like crystals of 2,4-dichloro-6-methoxyquinoline. Yield 127, melting point 175-176°C Reference example 4 4-chloro-5,8-dimethoxycarbostyryl 157
60% methanol 500ml or ethanol 300ml
1 and then add 1.5y of reduction catalyst and an equivalent amount of N
Add aOH aqueous solution, H2lOk9/Cd, 50-60
Stir at ℃ for 2 hours.

触媒を沢去、乾固して5・8−ジメトキシ−3・4ジヒ
ドロカルボスチリルを得る。収量11.5y、収率88
45%、融点98〜99℃参考例 5 5・8−ジメトキシ−3・4−ジヒドロカルボスチリル
57を47%HBr5Omlに加え2時間還流する。
The catalyst was removed and dried to obtain 5,8-dimethoxy-3,4 dihydrocarbostyryl. Yield 11.5y, Yield 88
45%, melting point 98-99°C Reference Example 5 5,8-dimethoxy-3,4-dihydrocarbostyryl 57 was added to 50ml of 47% HBr and refluxed for 2 hours.

冷却後析出晶を沢取、水100m1に投入する。一度溶
けたのち再び析出する。沢取、水洗、乾燥を行ない5・
8−ジヒドロキシ−3・4−ジヒドロカルボスチリルを
得る。収量3.57、収率81.4%、融点223〜2
24.5℃以下に本発明の化合物についてその抗菌性を
測定した結果を示す。ィンゲン葉に薬剤を筆で塗布、風
乾後インゲン菌核病菌の菌そうデイスクを葉上に静置し
、22℃の温室に3日間保ち、発病を調査した。
After cooling, the precipitated crystals were poured into a 100 ml pot of water. Once melted, it precipitates again. Sawatori, washing with water, drying 5.
8-dihydroxy-3,4-dihydrocarbostyryl is obtained. Yield 3.57, yield 81.4%, melting point 223-2
The results of measuring the antibacterial properties of the compounds of the present invention at temperatures below 24.5°C are shown. The chemical was applied to French bean leaves with a brush, and after air-drying, a fungal disc of French bean Sclerotinia fungi was placed on the leaves and kept in a greenhouse at 22°C for 3 days to investigate the onset of disease.

尚、下記基準に従つて求めた処理区又は無処理区(各3
区、1区当り各5葉)の発病指数の平均をそれぞれの発
病度とした。防除価を下記式に従つて求めた。
In addition, treatment area or non-treatment area (3 each) determined according to the following criteria.
The average disease index of each ward (5 leaves per ward) was taken as the respective disease severity. The control value was calculated according to the following formula.

その結果を下記に表示する。尚表中の防除価についての
評価は夫々次のことを示す。
The results are shown below. The evaluation of the control value in the table shows the following.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ (式中Xはハロゲン原子を示す。 またR_1、R_2及びR_3は水素原子または低級ア
ルコキシ基を示す。但しR_1及びR_3が低級アルコ
キシ基のときはR_2は水素原子を、R_1及びR_3
が水素原子のときはR_2は低級アルコキシ基を、また
R_1及びR_2が水素原子のときはR_3は低級アル
コキシ基を示す)で表わされるキノリン誘導体。
[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, When it is a lower alkoxy group, R_2 is a hydrogen atom, R_1 and R_3
is a hydrogen atom, R_2 represents a lower alkoxy group, and when R_1 and R_2 are hydrogen atoms, R_3 represents a lower alkoxy group).
JP52074648A 1977-06-22 1977-06-22 Quinoline derivatives and their production method Expired JPS5919095B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP52074648A JPS5919095B2 (en) 1977-06-22 1977-06-22 Quinoline derivatives and their production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52074648A JPS5919095B2 (en) 1977-06-22 1977-06-22 Quinoline derivatives and their production method

Publications (2)

Publication Number Publication Date
JPS549284A JPS549284A (en) 1979-01-24
JPS5919095B2 true JPS5919095B2 (en) 1984-05-02

Family

ID=13553248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52074648A Expired JPS5919095B2 (en) 1977-06-22 1977-06-22 Quinoline derivatives and their production method

Country Status (1)

Country Link
JP (1) JPS5919095B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146759A (en) * 1981-03-06 1982-09-10 Otsuka Pharmaceut Co Ltd Preparation of 5-hydroxycarbostyril
JPS57149270A (en) * 1981-03-12 1982-09-14 Otsuka Pharmaceut Co Ltd Preparation of 3,4,5,6,7,8-hexahydrocarbostyril-5-one
HU188235B (en) * 1982-12-11 1986-03-28 Alkaloida Vegyeszeti Gyar,Hu Process for producing fluoro-methyl-quinoline derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5030884A (en) * 1973-05-19 1975-03-27

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5030884A (en) * 1973-05-19 1975-03-27

Also Published As

Publication number Publication date
JPS549284A (en) 1979-01-24

Similar Documents

Publication Publication Date Title
JPH0778065B2 (en) (6,7-Substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid-O ▲ above 3 ▼, O ▲ above 4) bis (acyloxy-O) Boron compound, salt thereof, and method for producing the same
Agui et al. Studies on quinoline derivatives and related compounds. 1. A new synthesis of 1‐alkyl‐1, 4‐dihydro‐4‐oxo‐3‐quinolinecarboxylic acids
JPS6141917B2 (en)
JPH0148911B2 (en)
DK145099B (en) METHOD OF ANALOGY FOR PREPARATION OF PYRIDAZINE DERIVATIVES
JPS5919095B2 (en) Quinoline derivatives and their production method
JPH0768219B2 (en) Process for producing quinolinecarboxylic acid
CA1173445A (en) Quinolone derivatives and their use as pharmaceuticals
CA2199645C (en) Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof
Song et al. Improved synthesis of quinaldines by the Skraup reaction
KR101041551B1 (en) Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
JPH0374671B2 (en)
JPH0215066A (en) Intermediate for producing flumequine
KR930003072B1 (en) Process for preparation of quinolone carboxylic acid derivatives
US5578728A (en) Process for the preparation of a benzo(a)quinolizione derivative
Price et al. Synthesis of 4-Hydroxyquinolines. II. Preparation Through 3-Cyano and 3-Carbanilido Derivatives1
WO1987003594A1 (en) Amifloxacine intermediate
US4898945A (en) Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid
CA1159832A (en) Process for preparing flumequine
JPS5840949B2 (en) Method for producing 5,8-dihydroxy-3,4-dihydrocarbostyryl
US3840544A (en) Alkyl 4-alkoxy-7-(pyridyl)-3-quinoline-carboxylates,their preparation and conversion to corresponding 4-oxo compounds
US4272440A (en) Intermediates for preparing hydroxyphenylpyridazinones
JPS6216955B2 (en)
US4216325A (en) 4-(p-Fluorobenzoyl)-1-[3-(p-fluorobenzoyl)propyl]piperidine
JPS6127393B2 (en)